Cite
Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases
MLA
Sylvie Friard, et al. “Durable Responses to Immunotherapy of Non-Small Cell Lung Cancers Harboring MET Exon-14-Skipping Mutation: A Series of 6 Cases.” Lung Cancer (Amsterdam, Netherlands), vol. 150, June 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f857e56be49300c3ad23090a8c2fcec&authtype=sso&custid=ns315887.
APA
Sylvie Friard, Marie-Ange Massiani, Christos Chouaid, Hélène Doubre, Anne-cecile Metivier, Leila Zemoura, Laure Tabèze, Marie Mayenga, Céline Callens, Elisabeth Longchampt, Jean-Baptiste Assié, Samia Melaabi, Isabelle Monnet, Séverine Fraboulet, & Louis-Jean Couderc. (2020). Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases. Lung Cancer (Amsterdam, Netherlands), 150.
Chicago
Sylvie Friard, Marie-Ange Massiani, Christos Chouaid, Hélène Doubre, Anne-cecile Metivier, Leila Zemoura, Laure Tabèze, et al. 2020. “Durable Responses to Immunotherapy of Non-Small Cell Lung Cancers Harboring MET Exon-14-Skipping Mutation: A Series of 6 Cases.” Lung Cancer (Amsterdam, Netherlands) 150 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f857e56be49300c3ad23090a8c2fcec&authtype=sso&custid=ns315887.